gastroparesis from glp 1 New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Diabetic Gastroparesis - GT health
Description
Compared to classical exenatide given twice daily (BID, the once-weekly (QW) formulation at a 2 mg dose level provides a relatively stable plasma concentration at steady-state (300 pg/ml) because of the more continuous delivery of the drug, with equal (or slightly improved) efficacy on glycemic control and body weight after 24 and 30 wk of treatment [888]
Neurochem Int 2007
Self-insured employers are bigger companies with more resources that hire an insurer like Blue Cross to administer an insurance plan, but the employer assumes the risk of claims exceeding premiums
They do
